United States · FDA National Drug Code directory
Panzyga
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68982-822_f5c107e3-09fc-5566-7f81-10904807e942
- Product NDC
- 68982-822
- Form
- SOLUTION
- Composition / generic term
- immune globulin intravenous (human)
- Labeler
- Octapharma USA Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20181112
- Source listing expiry
- 20271231
Source-listed ingredients
- HUMAN IMMUNOGLOBULIN G — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (68982-822-01) / 10 mL in 1 BOTTLE, GLASS (68982-822-81) · 68982-822-01
- 1 BOTTLE, GLASS in 1 CARTON (68982-822-02) / 25 mL in 1 BOTTLE, GLASS (68982-822-82) · 68982-822-02
- 1 BOTTLE, GLASS in 1 CARTON (68982-822-03) / 50 mL in 1 BOTTLE, GLASS (68982-822-83) · 68982-822-03
- 1 BOTTLE, GLASS in 1 CARTON (68982-822-04) / 100 mL in 1 BOTTLE, GLASS (68982-822-84) · 68982-822-04
- 1 BOTTLE, GLASS in 1 CARTON (68982-822-05) / 200 mL in 1 BOTTLE, GLASS (68982-822-85) · 68982-822-05
- 1 BOTTLE, GLASS in 1 CARTON (68982-822-06) / 300 mL in 1 BOTTLE, GLASS (68982-822-86) · 68982-822-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →